financetom
Business
financetom
/
Business
/
Riot Platforms Stock Falls After Weaker April Bitcoin Production Report: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Riot Platforms Stock Falls After Weaker April Bitcoin Production Report: What's Going On?
May 26, 2025 1:17 AM

Riot Platforms, Inc. ( RIOT ) shares are trading lower Monday following the release of its April 2025 production and operations update.

What To Know: The company mined 463 Bitcoin in April, down 13% from March's 533. The daily average production also declined from 17.2 BTC to 15.4 BTC, a 10% decrease month-over-month. Riot attributed the drop to two consecutive network difficulty adjustments during the month.

Despite the decline in production, year-over-year figures showed improvement, with a 23% increase in both total and daily average Bitcoin mined compared to April 2024. The company sold all 475 Bitcoin produced in April, generating $38.8 million in net proceeds at an average price of $81,731 per coin. Riot stated it chose to sell its Bitcoin to fund growth and operations, aiming to limit dilution from equity fundraising.

Hash rate metrics were flat or slightly down. The deployed hash rate remained unchanged at 33.7 EH/s, while the average operating hash rate slipped 3% from March to 29.3 EH/s. Power credits rose to $2 million, more than doubling from the previous month. Riot also completed its acquisition of Rhodium's assets at the Rockdale Facility during April, ending its last remaining hosting agreement and fully exiting the Bitcoin hosting business.

RIOT Price Action: Riot shares were down 7.37% at $7.795 at the time of writing, according to Benzinga Pro.

Read Next:

Strategy Acquires 1,895 BTC For $180 Million As Bitcoin ETFs Bounce Back With $1.8 Billion Inflow

Image Created Via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch
Feb 21, 2025
(Reuters) - Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ending its tumultuous journey in the public markets as it struggled with a severe cash crunch. Bluebird bio, which raised going concern doubts for the first time three years ago, laid off about 25% of its workforce in 2024...
Neurocrine Biosciences Approves $500 Million Share Repurchase Program
Neurocrine Biosciences Approves $500 Million Share Repurchase Program
Feb 21, 2025
08:18 AM EST, 02/21/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday its board authorized a new share repurchase program allowing the company to buy back up to $500 million of its shares. The company said the new authorization is in addition to the $300 million accelerated repurchase program launched in October 2024, which was completed in early...
Laramide Resources Reports Final Results from 2024 Drill Campaign at Westmoreland Project in Australia
Laramide Resources Reports Final Results from 2024 Drill Campaign at Westmoreland Project in Australia
Feb 21, 2025
08:16 AM EST, 02/21/2025 (MT Newswires) -- Laramide Resources ( LMRXF ) reported Friday final results from its 2024 drill campaign at the Westmoreland uranium project in Australia. Highlights include 8.00 meters at 325.61 parts per million (ppm) uranium from the Junnagunna deposit, 3.00 meters at 853.74 ppm uranium from the Amphitheatre deposit, and 260.04 ppm uranium and 1,082.19 ppm...
Intra-Cellular Therapies Q4 Net Loss Narrows, Revenue Rises
Intra-Cellular Therapies Q4 Net Loss Narrows, Revenue Rises
Feb 21, 2025
08:16 AM EST, 02/21/2025 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) reported a Q4 net loss Friday of $0.16 per diluted share, compared with a loss of $0.29 a year earlier. Analysts polled by FactSet expected a loss of $0.07. Total revenue for the quarter ended Dec. 31 was $199.2 million, up from $132.1 million a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved